Idenix Pharmaceuticals Inc

Type: Company
Name: Idenix Pharmaceuticals Inc
Nationality: United States
Web Address: http://www.idenix.com/
First reported Oct 24 2014 - Updated Oct 24 2014 - 1 reports

Ex-Bank of New York Mellon employee pleads guilty to insider trading

FACTBOX-The late Mbulaeni Mulaudzi Reuters - 8 minutes agoAt least four dead in escape bid at model Dominican Republic jail Reuters - 12 minutes agoU.S. TV startup Roku to confidentially file for IPO: WSJ Reuters - 13 minutes agoRalph Nader urges Apple ... [Published Yahoo! Maktoob News - Oct 24 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 1 reports

Ex-BNY Mellon employee pleads guilty in insider case

David L. Post reaped more than $700,000 in the scheme with a former classmate who worked at Merck & Co.EmailShareShare(Bloomberg) -- An ex-Bank of New York Mellon Corp. employee pleaded guilty to participating in an insider-trading scheme with a former ... [Published Crains NY Business - Oct 24 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 3 reports

SEC announces insider trading charges for N.J. man for pharmaceutical acquisition knowledge

Market Pulse The Securities and Exchange Commission on Friday announced insider trading charges against David Post of Livingston, N.J., who generated nearly $700,000 in illicit profits after receiving tips that two pharmaceutical companies were about ... [Published TD Ameritrade - Oct 24 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

Nine Takeover Targets of 2014

So many mergers and acquisition deals have gone done this year that GEN was able to expand its list of companies ripe for takeover from last year’s List .But in growing to nine companies from seven in 2013, the List also shows what has remained the same ... [Published Genetic Engineering News - Oct 20 2014]
First reported Oct 17 2014 - Updated Oct 17 2014 - 1 reports

Former pharmaceutical employee charged with insider trading

A former senior financial analyst for a major pharmaceutical company has been arrested on charges of insider trading of pharmaceutical stocks, according to a press release issued by the US Attorney’s Office, Southern District of New York.Zachary Zwerko, ... [Published Orthopedics Today - Oct 17 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

Former Merck Analyst Shared Merger Tips, Faces Insider Trading Charges

Federal prosecutors have charged Zachary Zwerko, former senior finance analyst at Merck, with conspiracy to commit fraud for tipping a contact about potential mergers, including Merck's takeover of Idenix Pharmaceuticals.According to the complaint, Zwerko ... [Published Pharmaceutical Manufacturing Magazine - Oct 16 2014]
First reported Oct 15 2014 - Updated Oct 16 2014 - 2 reports

Ex-Merck Analyst Hit with Insider Trading Rap

A former Merck financial analyst who prosecutors say had access to confidential information about planned acquisitions has been charged with taking part in an insider trading scheme that allegedly enabled a friend to make about $722,000 in illicit pr ... [Published CFO.com - Oct 15 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

Ex-Merck employee charged in biotech's latest insider trading scheme

This summer, as Merck ($MRK) inched closer and closer to its $3.9 billion buyout of Idenix Pharmaceuticals, one of the company's employees tipped off a friend that a deal was imminent, federal prosecutors say. With that information, the pair made hundreds ... [Published FierceBiotech - Oct 15 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 2 reports

Repo Rules, Tipper Charged, Broken Windows: Compliance

Traders are facing new global ruleson how they determine the value of collateral in repotransactions as regulators seek to prevent panic writedowns thatare seen fueling future financial crises.The Financial Stability Board, a global group that bringstogether ... [Published Bloomberg - Oct 15 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

Cambridge man charged with insider trading

A former Merck & Co. Inc. pharmaceutical analyst from Cambridge was charged Tuesday with insider trading after he allegedly tipped off a business school classmate about two potential mergers that allowed the friend to make $683,000,authorities said.The ... [Published Boston Globe - Oct 15 2014]
First reported Oct 14 2014 - Updated Oct 14 2014 - 1 reports

Merck Sharp and Dohme to present hepatitis insights at AASLD 2014

:08 in Pharmaceutical Company Product News Merck Sharp and Dohme has announced it will be attending the 2014 annual meeting of the American Association for the Study of Liver Diseases (AASLD), where it will share its latest hepatitis C drug research findings. ... [Published Zenopa - Oct 14 2014]
First reported Oct 01 2014 - Updated Oct 02 2014 - 1 reports

Merck completes sale Bayer

Drugmaker Merck says it's completed the sale of its consumer care business, which makes products including Claritin allergy medication and Coppertone sun-care line, to German health care company Bayer for $US14.2 billion ($A15.36 billion).Bayer AG ... [Published Sky News Australia - Oct 01 2014]

Quotes

"Post and Zwerko tried to keep law enforcement authorities in the dark by using prepaid cell phones and a dummy e-mail account to communicate inside information, and Post doled out the kickbacks inside his own home" Sanjay Wadhwa, senior associate director of the SEC's New York regional office, said in a statement
"I want to apologize to the court for my conduct" said a tearful Mr. Post, who had to stop twice to compose himself
...Eliav Barr , vice president, Infectious Diseases, Merck Research Laboratories . "Merck's broad and systematic hepatitis C clinical development program is designed with this goal in mind, and is generating important insights into the potential of grazoprevir/elbasvir across multiple viral genotypes and patient populations."
A study published in the Journal the Value of Health discussed the cost-effectiveness of a "noncalcium-based phosphate binder lanthanum carbonate (LC) as second-line treatment of hyperphosphatemia after therapy failure with calcium-based binders (NYSE: CB )." It would appear that there is an alternative to taking calcium carbonates that is not only cost effective but also has clinical benefits...

More Content

All (127) | News (58) | Reports (0) | Blogs (55) | Audio/Video (0) | Fact Sheets (1) | Press Releases (11)
sort by: Date | Relevance
Ex-Bank of New York Mellon employee pleads guil... [Published Yahoo! Maktoob News - Oct 24 2014]
Ex-BNY Mellon employee pleads guilty in insider... [Published Crains NY Business - Oct 24 2014]
SEC announces insider trading charges for N.J. ... [Published TD Ameritrade - Oct 24 2014]
SEC Charges New Jersey Man in Insider Trading C... [Published 4 Traders - Oct 24 2014]
SEC Charges New Jersey Man in Insider Trading C... [Published SEC US Press Releases - Oct 24 2014]
Ex-Bank Of New York Mellon Trader Pleads Guilty... [Published Clusterstock - Oct 24 2014]
Regulus Gets Seat at Hep C Table With Today's I... [Published TheStreet.com - Oct 22 2014]
Nine Takeover Targets of 2014 [Published Genetic Engineering News - Oct 20 2014]
Former pharmaceutical employee charged with ins... [Published Orthopedics Today - Oct 17 2014]
Former Merck Analyst Shared Merger Tips, Faces ... [Published Pharmaceutical Manufacturing Magazine - Oct 16 2014]
Merck to Present New Data from Clinical Studies... [Published 4 Traders - Oct 15 2014]
Ex-Merck Analyst Hit with Insider Trading Rap [Published CFO.com - Oct 15 2014]
The Second Time Around Analyst Is Charged With ... [Published JD Supra - Oct 15 2014]
Ex-Merck employee charged in biotech's latest i... [Published FierceBiotech - Oct 15 2014]
Repo Rules, Tipper Charged, Broken Windows: Com... [Published Bloomberg - Oct 15 2014]
Repo Rules, Tipper Charged, Broken Windows Crit... [Published GARP - Oct 15 2014]
Cambridge man charged with insider trading [Published Boston Globe - Oct 15 2014]
Merck Sharp and Dohme to present hepatitis insi... [Published Zenopa - Oct 14 2014]
Why Did Baupost Double Its Stake In Keryx Bioph... [Published Seeking Alpha - Oct 13 2014]
Keryx Biopharmaceuticals (KERX): Baupost Group ... [Published InsiderMonkey.com - Oct 10 2014]
Gilead wins FDA approval for its hep C combo pi... [Published FierceBiotech - Oct 10 2014]
Merck completes sale Bayer [Published Sky News Australia - Oct 01 2014]
Merck completes sale of consumer unit to Bayer [Published Yahoo! Malaysia - Oct 01 2014]
J&J's Alios Buyout Bodes Interesting Times For ... [Published Investor's Business Daily - Sep 30 2014]
Johnson & Johnson Bets $1.75 Billion On Alios Buy [Published Yahoo! Finance - Sep 30 2014]
J&J Buying Alios, Going Up Against Gilead [Published Investor's Business Daily - Sep 30 2014]
J&J makes a splash in hep C with a $1.75B deal ... [Published FierceBiotech - Sep 30 2014]
Gilead nears EU approval for the next big thing... [Published FierceBiotech - Sep 26 2014]
The 5 Best Biotech Stocks in 2014...so far [Published Motley Fool - Sep 26 2014]
The FDA Said It Has Granted Accelerated Approva... [Published Seeking Alpha - Sep 23 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Ex-Bank Of New York Mellon Trader Pleads Guilty... [Published Clusterstock - Oct 24 2014]
By Joseph Ax NEW YORK (Reuters) - A former Bank of New York Mellon Corp trader on Friday pleaded guilty to insider trading based on tips from a former Merck & Co Inc employee about potential pharmaceutical mergers. Federal prosecutors in New York ...
Akebia Therapeutics Appoints Ronald C. Renaud J... [Published Business Wire Health News - Sep 15 2014]
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products ...
Merck – Preparing For The Next Move [Published Chimera Research Group - Proceed With Confidence - Aug 11 2014]
  Merck & Co. Inc. (MRK) -NYSE   Lately, Merck was under the spot light after Idenix Pharmaceuticals deal, paying $3.85 Billion more than triple Idenix’s market capitalization before the. The post Merck – Preparing For The Next Move appeared first ...
Merck Completes Tender Offer to Acquire Idenix [Published EON Business - Aug 05 2014]
WHITEHOUSE STATION, N.J.--(EON: Enhanced Online News)--Merck announced the successful completion of the tender offer for all of the outstanding shares of common stock of Idenix Pharmaceuticals, Inc. at a purchase price of $24.50 per share. ...
Merck Completes Tender Offer to Acquire Idenix [Published Business Wire Professional Services News - Aug 05 2014]
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck announced the successful completion of the tender offer for all of the outstanding shares of common stock of Idenix Pharmaceuticals, Inc. at a purchase price of $24.50 per share. ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
SEC Charges New Jersey Man in Insider Trading C... [Published SEC US Press Releases - Oct 24 2014]
Idenix Pharmaceuticals Reports Second Quarter a... [Published GlobeNewswire: Advertising News - Jul 31 2014]
The Zacks Analyst Blog Highlights: AbbVie, Gile... [Published Financial Services - Jun 17 2014]
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announc... [Published Financial Services - Jun 13 2014]
SHAREHOLDER ALERT: Pomerantz LLP Investigates C... [Published Financial Services - Jun 13 2014]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.